A. H. Belo Corporation Announces Termination of Agreement to Sell Property
DALLAS, Dec. 10, 2018 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) announced today that on December 6, 2018, the […]
Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis
Company also announces first patient enrolled in clinical trial of XHANCE for treatment of nasal polyps in pediatric patients YARDLEY, […]
Hamilton Lane Again Named a ‘Best Place to Work’ by both Pensions & Investments and Central Penn Business Journal
Seventh consecutive recognition for both awards BALA CYNWYD, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) — Hamilton Lane (NASDAQ: HLNE) has […]
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
Company to Conduct Conference Call and Webcast Today at 8:00am ET / 5:00am PT REDWOOD CITY, Calif., Dec. 10, 2018 […]
Axovant Reports Results of Exploratory Phase 2 Clinical Study of Nelotanserin in Lewy Body Dementia Patients Experiencing REM Sleep Behavior Disorder
Primary efficacy endpoint assessed by sleep laboratory video assessment was not met Axovant is discontinuing clinical development of nelotanserin BASEL, […]
Axsome Therapeutics Announces Positive Outcome of Interim Analysis of ADVANCE-1 Phase 2/3 Trial of AXS-05 in Alzheimer’s Disease Agitation
IDMC recommends continuation of trial evaluating AXS-05 versus placebo in Alzheimer’s disease agitation IDMC recommends no further enrollment to single-agent […]
Trevena Promotes Robert T. Yoder to Senior Vice President and Chief Business Officer
CHESTERBROOK, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) — Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and […]
Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead
EMERYVILLE, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) — Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next […]
Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) — Apricus Biosciences, […]
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, December 12, 2018
Conference Call and Webcast To be Held Wednesday, December 12, 2018 at 4:30pm Eastern Time NEW YORK, Dec. 10, 2018 […]
